Difference between revisions of "Talk:Remaining lifetime risk of CVD death in adults"
From Testiwiki
(New page: {{discussion |Dispute= ERF of n-3 PUFA and risk of CVD death |Outcome= Under discussion (to be changed when a conclusion is found) | Argumentation ={{comment|#(1):|The study by Fernandez-J...) |
(Parameters corrected) |
||
| Line 1: | Line 1: | ||
| − | {{discussion | | + | {{discussion |
| − | Argumentation ={{comment| | + | |Statements= ERF of n-3 PUFA and risk of CVD death |
| + | |Resolution= Under discussion (to be changed when a conclusion is found) | | ||
| + | Argumentation= | ||
| + | {{comment|1|The study by Fernandez-Jarne et al provides ERF of n-3 PUFA intake on risk of nonfatal acute myocardial infarction (AMI). On the other hand the ERF of Hg corresponds to the risk of CVD death. Therefore, the joint effect of Hg and n-3 PUFA on a single health endpoint cannot be examined.}} | ||
| + | }} | ||
Latest revision as of 12:44, 16 November 2009
| Statements: ERF of n-3 PUFA and risk of CVD death
Resolution: Under discussion (to be changed when a conclusion is found) (A stable resolution, when found, should be updated to the main page.) |
| Argumentation:
--1: The study by Fernandez-Jarne et al provides ERF of n-3 PUFA intake on risk of nonfatal acute myocardial infarction (AMI). On the other hand the ERF of Hg corresponds to the risk of CVD death. Therefore, the joint effect of Hg and n-3 PUFA on a single health endpoint cannot be examined. {{{3}}} |
